The cellular and molecular mechanisms underlying senile osteoporosis remain poorly understood. In this study, transgenic mCol1α1-Pitx1 mice overexpressing paired-like homeodomain 1 (PITX1), a homeobox transcription factor, rapidly develop a severe type-II osteoporotic phenotype with significant reduction in bone mass and biomechanical strength similar to that seen in humans and reminiscent of the phenotype previously observed in Sca-1 (Ly6a)-null mice. PITX1 plays a critical role in hind limb formation during fetal development, while loss of expression is associated with primary knee/ hip osteoarthritis in aging humans. Through in vivo and in vitro analyses, we demonstrate that Pitx1 directly regulates the self-renewal of mesenchymal progenitors and indirectly regulates osteoclast differentiation through the upregulation of Wnt signaling inhibitors DKK1, SOST, and GSK3-β. This is confirmed by elevated levels of plasma DKK1 and the accumulation of phospho-β-catenin in transgenic mice osteoblasts. Furthermore, overexpressed Pitx1 in mice osteoblasts results in severe repression of Sca-1 (Ly6a) that was previously associated with senile osteoporosis. Our study is the first to demonstrate the novel roles of PITX1 in senile osteoporosis where PITX1 regulates the self-renewal of mesenchymal stem cells or progenitor cells through Sca-1 (Ly6a) repression and, in addition, inhibits the Wnt signaling pathway.
. Transgenic Col1α1-Pitx1 mice exhibit growth retardation accompanied with bone loss. (A) Comparative photo of both sexes from 12-week-old transgenic mCol1α1-Pitx1 and wild type mice. (B) Comparative growth curves of both sexes of mCol1α1-Pitx1 mice and their corresponding wild type littermates over a 28-week period. (C) X-ray imaging of 12-week-old female mCol1α1-Pitx1 and wild type mice confirm a very thin and fragile cortical bone in long bones. The femur length of both sexes of transgenic mCol1α1-Pitx1 mice and their corresponding wild type littermates over a 28-week period are also shown. (D) Histological examination of the distal femoral growth plates for the study of growth differences of long bones. Structural abnormalities of growth plates were observed in safranin O-stained sections of transgenic mCol1α1-Pitx1 mice. Mean proteoglycan content in transgenic growth plates was determined by measuring changes in safranin O color intensity using the Image J software. Proteoglycan content of transgenic mouse growth plates showed a reduction of 60% when compared to the wild type mouse growth plate.
Pitx1 overexpression reduces bone length and bone mass.
Radiological analysis revealed a 10.7% and 11.1% reduction in femur length of adult transgenic mice for females (P = 0.01) and males (P = 0.007), respectively (Fig. 1C ). Given the central role of chondrocyte proliferation and differentiation in the growth of long bones, histological examination of the distal femoral growth plates was performed. Structural abnormalities of growth plates were observed in safranin O-stained sections of transgenic mCol1α1-Pitx1 mice (Fig. 1D) . The proliferation and hypertrophy zones were narrower than in the wild type mice. The proliferation zone displayed visibly lower number of cells, and this was accompanied with irregular chondrocyte organization that failed to form distinct columns. In addition, chondrocytes appeared smaller and isolated in a poorly stained matrix. ImageJ software was used to quantify the intensity of safranin O staining and showed 59% reduction in the proteoglycan content when compared to the wild type littermates (wild type [mean ± SD, arbitrary units]: 95.7 ± 8.8 and transgenic: 39.3 ± 9.5).
Bone mineral density (BMD) measurements of whole femurs of transgenic and wild type mice showed a 15.9% and 13.4% reduction in transgenic females (P = 0.014) and transgenic males (P = 0.023) respectively, compared with wild type mice at 12 weeks of age ( Supplementary Fig. S1 ). Similarly, the bone mineral content (BMC) was reduced by 13.3% in females (P = 0.05), and 23.3% in males (P = 0.05) compared with wild type mice ( Supplementary Fig. S1 ). The decrease in bone mass was observed in females throughout the 28-week observation period. In transgenic males, the bone mass was decreased prior the first 20 weeks of observation and then became similar to that of wild type mice. These observations indicate that bone mass is reduced with Pitx1 overexpression in mice osteoblasts.
Pitx1 overexpression impairs bone microarchitecture and biomechanical strength.
To determine the physiological effects of decreased mineral content in transgenic mCol1α1-Pitx1 mice, structural and mechanical analyses were performed. Microcomputed tomography (μCT) was used to analyze the structural parameters of the trabecular and cortical bones of femurs harvested from 12-week-old transgenic and wild type mice of both sexes. Three-dimensional images showed alterations in the trabecular bones of transgenic mice when compared to those of wild type mice ( Fig. 2A-D) . Quantitation of the structural parameters revealed that the trabecular bone surface over bone volume (Tb.BS/BV) and the trabecular pattern factor (Tb.Pf) were increased by 23.1% and 10.4%, respectively, in transgenic females (P < 0.01), and increased by 31.4% and 55.4%, respectively, in transgenic males (P < 0.01) ( Fig. 2E,F ). Trabecular pattern factor (Tb.Pf) describes the relative convexity/concavity of the total bone surface and is the reciprocal measurement of trabecular network connectivity 8 . Indeed, (E-H) Quantitative comparison of the trabecular bone parameters: Bone surface (BS)/Bone volume (BV); pattern factor (Pf); thickness (Th); structure model index (SMI). Data are presented as mean ± SD for 5 mice from each sex in each genotype group. Asterisks indicate statistically significant difference (*p < 0.05; **p < 0.005; ***p < 0.0005).
www.nature.com/scientificreports www.nature.com/scientificreports/ increased Tb.Pf values in transgenic mice represent the presence of isolated, disconnected structures (struts) and reflect a weak trabecular network ( Fig. 2F ). Conversely, trabecular thickness (Tb.Th) was decreased by 22.8% in transgenic females (P < 0.01) and by 19% (P < 0.01) in transgenic males ( Fig. 2G) . Additionally, the structure model index (SMI), used to determine plate or rod-like geometry of trabecular structures 9 , also decreased by 11.5% in transgenic females (P < 0.01) and by 16.7% (P < 0.01) in transgenic males ( Fig. 2H ), indicating a shift from rod-like trabecular architecture to a plate-like one. Trabecular bone volume (Tb.BV/TV) and trabecular number (Tb.N) were also measured in 12 week-old wild type and transgenic mice, but they showed no significant difference in males (P = 0.09 and P = 0.340, respectively) or females (P = 0.293 and P = 0.080, respectively) ( Supplementary Fig. S2 ). Quantitation of the structural parameters in cortical bones revealed that the cortical bone volume density (Ct.BV/TV) and the cortical thickness (Ct.Th) were decreased by 7.2% and 55.6%, respectively, in transgenic females (P < 0.01) and by 6.5% and 62.5%, respectively, in transgenic males (P < 0.01) ( Fig. 3A -D) compared to the wild type mice. Conversely, the cortical bone surface over bone volume (Ct.BS/BV) and the cortical porosity (Ct.porosity) were significantly increased in transgenic mice by 54% and 81.6%, respectively, in females (P < 0.01) and by 64.4% and 87%, respectively, in males (P < 0.01) ( Fig. 3E-F) . The biomechanical strength of freshly dissected femurs was evaluated by a three-point bending test. Consistent with the BMC and BMD data, the three-point bending test of femurs revealed a decrease in the bone strength in transgenic mice by 45.8% in females (P = 0.03) and 33.8% in males (P = 0.025) compared to wild type mice (Fig. 3G ). The ultimate force parameter was significantly reduced in femurs isolated from transgenic mice (10.6 ± 0.3 N, P < 0.005 in females and 16.5 ± 4 N, P < 0.05 in males) compared to wild type mice (16.7 ± 1.4 N in females and 23.7 ± 2 N in males) (Fig. 3H ). The work to ultimate point was significantly reduced by 53.8% in transgenic females (P = 0.05) and by 58.3% in transgenic males (P = 0.0007) compared to wild type mice ( Fig. 3I ). Collectively, our data reveal that adult transgenic mice overexpressing Pitx1 in bone tissues have reduced bone mass density, compromised microarchitecture, and reduced biomechanical bone strength compared with wild type mice. bone mass in transgenic mice was due to decreased bone formation, we performed static and dynamic bone histomorphometry analysis on sections of undecalcified femurs of wild type and transgenic mice at 12 weeks of age. Goldner's trichrome and toluidine blue staining revealed reduced number of osteoids in the cortical bones of transgenic mice ( Fig. 4A-D) . Transgenic mice exhibited a significant decrease in trabecular perimeters occupied by osteoids, presented as the ratio of the osteoid surface to bone surface (OS/BS), with a reduction of 64.2% in females (P = 0.003) and 85% in males (P = 0.007) ( Fig. 4E ). In addition, transgenic mice displayed a significant decrease in the osteoid volume over bone volume (OV/BV) only in females (67.9%, P = 0.012), while such decrease nearly approached significance in males (67.3%, P = 0.054) ( Fig. 4F ). Among bone formation parameters, the number of osteoblasts lining the trabecular bone (N.Ob/B.Pm) and the percentage of bone surface occupied by osteoblasts (Ob.S/BS) significantly decreased by 64.4% in transgenic females (P = 0.003) and 77.3% in transgenic males (P = 0.007) compared with wild type mice ( Fig. 4G ). We also observed a significant reduction in the mineralized surface, bone formation rate, and mineral appositional rate in transgenic mice as demonstrated by dynamic histomorphometric analysis of femurs from 12-week-old transgenic mCol1α1-Pitx1 and wild type mice ( Supplementary Fig. S3 ). Indeed, the bone formation rate (BFR/BS), mineral apposition rate (MAR), and the mineralizing surface (MS/BS) were all significantly reduced in transgenic mice compared with wild type mice ( Supplementary Fig. S3 ). Our data demonstrate that Pitx1 overexpression induces altered mineralization, defects in bone formation and osteoid deposition, resulting in low BMD and altered microarchitecture in transgenic mice.
Overexpression of Pitx1 affects osteoblast differentiation and mineralization. To investigate changes in osteoblast differentiation, we used alkaline phosphatase, which is correlated to bone formation, and alizarin red, a fluorescent dye for the detection of mineralized nodules in osteoblasts. We compared the formation of alkaline phosphatase (ALP)-positive colonies and the number of mineralized nodules (alizarin red staining) in primary osteoblast cultures derived from wild type and transgenic mice. Overexpression of Pitx1 in transgenic mice osteoblasts caused a reduction in the number of ALP-positive cells and mineralized nodules compared www.nature.com/scientificreports www.nature.com/scientificreports/ with wild type mouse osteoblasts over a 21-day culture period ( Fig. 5A,B ). Surfaces of mineralized nodules stained with alizarin red, estimated by ImageJ software, were at 95.7% and 39.7% in wild type and transgenic mouse osteoblasts respectively (wild type [mean ± SD, arbitrary units]: 14861 ± 6.8 and transgenic: 6170 ± 10.9) ( Fig. 5A ). We then examined the expression of genes related to osteoblast differentiation. The expression level of differentiation markers Runx2, Osx, Alp, and Ocn were significantly reduced in transgenic cells compared with wild type mice ( Fig. 5C ). Conversely, silencing Pitx1 expression in transgenic osteoblasts transfected with Pitx1-siRNA, was sufficient to rescue transgenic osteoblast differentiation and mineralization defects as well as to induce upregulation of tested osteoblast differentiation marker expression ( Fig. 5D ,E). Indeed, mineralized nodules were increased in transgenic osteoblasts transfected with siRNA targeting Pitx1 with an alizarin red stained surface at 82.5% (siRNA Pitx1 [mean ± SD, arbitrary units]: 12860 ± 7.5) compared to 29.5% in transgenic osteoblasts transfected with a scrambled sequence siRNA (Neg [mean ± SD, arbitrary units]: 4580 ± 3.4) and 22% in untransfected transgenic mice osteoblasts (Nt [mean ± SD, arbitrary units]: 3416 ± 9.2) ( Fig. 5D ). Of note, Pitx1 overexpression in wild type mouse osteoblasts infected with a lentivirus expressing Pitx1 led to a 4.1-fold increase in Pitx1 expression when compared to normal endogenous Pitx1 expression or cells infected with the empty lentivirus, and reproduced the effects observed in transgenic osteoblasts ( Fig. 5F,G) . Consistently, the surfaces of mineralized nodules stained with alizarin red were significantly decreased in lentivirus-infected wild type osteoblasts overexpressing Pitx1 with a surface estimated by ImageJ software at 0.9% (Pitx1 virus [mean ± SD, arbitrary units]: 3 ± 1.4) contrasting with the surface values of 92.8% obtained with either the wild type osteoblasts infected with the empty vector (DsRed [mean ± SD, arbitrary units]: 14405 ± 9.4) or 98.8% obtained with the uninfected www.nature.com/scientificreports www.nature.com/scientificreports/ osteoblasts (Nt [mean ± SD, arbitrary units]: 15842 ± 8.5) ( Fig. 5F ). Collectively, our results show that Pitx1 overexpression induces cell-autonomous differentiation and mineralization defects in primary mouse osteoblasts.
Transgenic mCol1α1-Pitx1 mice exhibit a defect in mesenchymal progenitors. To determine the origin of osteoprogenitor deficiency, equal numbers of nucleated bone marrow (BM) cells from 12-week-old transgenic and wild type mice were cultured. The number of colony forming units (CFU-F), the measure of total mesenchymal precursors including stem cells and committed progenitors formed in transgenic mCol1α1-Pitx1 mice cultures compared to wild type cultures was reduced by 48.8% (P = 0.012) ( Fig. 6A,B) . These data demonstrate that mesenchymal precursors are fewer in transgenic mice compared to wild type mice. Furthermore, CFU-ALP was also decreased in transgenic mesenchymal stem cells (MSCs) in osteogenic differentiation media, exhibiting a 31.4% reduction (P = 0.0006) in the number of osteogenic ALP + (CFU-ALP+) colonies, few mineralized nodules, and a downregulation of osteogenic markers compared with wild type MSCs under the same conditions ( Fig. 6C-E) . Conversely, silencing of Pitx1 expression by siRNA in transgenic MSCs decreased Pitx1 expression by 3.2-fold when compared to untransfected transgenic cells (NT) or those transfected with scrambled siRNA (Neg). Reduced Pitx1 expression levels in transgenic MSCs transfected with siRNA (siRNA Pitx1) increased their capacity to differentiate to mature osteoblasts as shown by the increase in mineralized nodules stained by alizarin red (4.5%) contrasting with values obtained with untransfected transgenic cells (NT -0.6%) or those transfected with scrambled siRNA (Neg -0.2%) ( Fig. 6F) . Similarly, the mRNA expression levels of osteogenic markers Runx2, Osx, Alp and Spp1, were elevated after silencing Pitx1 expression in transgenic osteoblasts ( Fig. 6G ). Of note, Pitx1 overexpression in lentivirus-infected wild type MSCs, increased Pitx1 expression by 2.4-fold compared to uninfected cells and reproduced the effects observed in transgenic MSCs (Fig. 6H,I) . Indeed, surfaces of mineralized nodules stained with alizarin red were decreased in lentivirus-infected wild type osteoblasts overexpressing Pitx1 with a stained surface of 6%, in contrast with the mineralized surface values www.nature.com/scientificreports www.nature.com/scientificreports/ obtained with either the wild type osteoblasts infected with the empty vector (DsRed -73.4%) or the uninfected osteoblasts (Nt -81.1%) (Fig. 6H) .
Diminished self-renewal of early mesenchymal progenitors in transgenic mice suggests that other mesenchymal lineages may be affected in a manner analogous to osteoprogenitors. Therefore, we studied adipogenesis in vitro. Consistent with the observed decrease in total stromal progenitors and osteoprogenitors, transgenic mCol1α1-Pitx1 bone marrow (BM) stroma contained significantly fewer adipocyte progenitors than in wild type mice ( Fig. 7A ). Of note, morphological and gene expression analysis revealed that the adipocyte progenitors did not appear to mature normally (Fig. 7B) . Given that defective mesenchymal stem or progenitor cell self-renewal was previously reported as age-dependent osteoporosis by Bonyadi et al., (2003) in Sca-1/Ly6A-null mice 10 , this prompted us to investigate a possible role of Pitx1 in the transcriptional regulation of the Sca-1/Ly6A gene. Indeed, overexpression of Pitx1 (Fig. 8A ) in transgenic mouse osteoblasts resulted in severe downregulation of endogenous Sca-1/Ly6a gene expression when compared to wild type mice osteoblasts (Fig. 8B ).
Osteoclastogenesis is affected by Pitx1 overexpression in a non-cell autonomous manner.
Osteoblasts play a key role in the regulation of osteoclast function. Therefore, it is of interest to investigate whether Pitx1 overexpression could interfere with the synthesis of paracrine osteoclast-regulating cytokines such as the receptor activator of nuclear factor kappa-B ligand (RANKL; encoded by Tnfsf11 gene) and osteoprotegerin (OPG; encoded by Tnfrsf11b gene). Expression analysis showed a significant decrease in Tnsfs11 (Rankl) expression in osteoblasts obtained from transgenic mice compared to those obtained from wild type mice (Fig. 8C) . Conversely, expression of Tnfrsf11b (Opg) was increased in transgenic osteoblasts compared to wild type mouse osteoblasts (Fig. 8D ). Histochemical evaluation revealed that the number of TRAP-positive osteoclasts in the trabecular bone decreased in transgenic mice by 77.3% in females (P = 0.013) and 58.3% in males (P = 0.037) compared to those in wild type mice ( Fig. 9A-C) . Histomorphometric analysis revealed a decrease in the percentage of the trabecular surface that is occupied by osteoclasts (Oc.S/BS) in transgenic mice (21.8% decrease in females and 37.3% decrease in males; P = 0.03) compared to wild type mice (Fig. 9D) . Consistently, we observed a significant elevation in the levels of the plasma RANKL decoy receptor, osteoprotegerin (OPG) in transgenic mice (12070.1 ± 794 pg/ml, P < 0.001 in females and 9766.3 ± 794 pg/ml, P < 0.001 in males) compared to wild type mice (7392.5 ± 359 pg/ml, P < 0.001 in females and 6899.5 ± 973 pg/ml, P < 0.001 in males) ( Fig. 9E ). Moreover, there was a significant decrease in the levels of the osteoclastogenic cytokine RANKL in transgenic mice (42 ± 6.3 pg/ml, P < 0.01 in females and 55.2 ± 9.3 pg/ml, P < 0.01 in males) compared to wild type mice (113.4 ± 20.7 pg/ml, P < 0.01 in females and 115.1 ± 38.5 pg/ml, P < 0.001 in males) (Fig. 9F) . This leads to a significant decrease in the RANKL/OPG ratio (Fig. 9G) . Collectively, our data strongly suggest that Pitx1 overexpression in transgenic mCol1α1-Pitx1 osteoblasts inhibits osteoclastogenesis in a non-cell autonomous manner.
Pitx1 overexpression inhibits the canonical Wnt/β-catenin signaling pathway. Osteoblast dif-
ferentiation is predominantly regulated by the canonical Wnt/β-catenin signaling pathway, which, together with bone morphogenetic proteins (BMP), regulates osteogenesis. We were therefore interested in whether Pitx1 overexpression could interfere with the Wnt/β-catenin signaling pathway. Expression analysis by quantitative www.nature.com/scientificreports www.nature.com/scientificreports/ real time PCR showed that the transcript levels of Sost and Dkk1, which are known inhibitors of Wnt signaling, increased by 4.1-fold (P = 0.005) and 6-fold (P = 0.0008), respectively, in transgenic mice osteoblasts compared to wild type mice cells (Fig. 10A) . We further demonstrated a significant increase in plasma Dkk1 levels in transgenic mice (1759 ± 908 pg/ml, P < 0.001) compared to wild type mice (621 ± 182 pg/ml, P < 0.001). No significant changes were observed in plasma Sost levels in transgenic mice (146 ± 24 pg/ml) compared to wild type mice (180 ± 43 pg/ml) (Fig. 10B ). In addition, Gsk3β expression also increased 5.4-fold (P = 0.001) in transgenic osteoblasts compared to wild type osteoblasts (Fig. 10A) . These results suggest that Pitx1 is a negative regulator of the canonical Wnt signaling pathway. Consistently, western blot analysis showed a significant increase in phospho-β-catenin in protein extracts of cultured transgenic osteoblasts compared to control cells (Fig. 10C ). This was further illustrated at the cellular level by immunofluorescence and confocal microscopy showing the presence of β-catenin in the nuclei (strong signal) and cytosol of wild type mice osteoblasts, while β-catenin was only detected in the cytosol of transgenic osteoblasts (Fig. 10D) . The same approach with anti-phospho-β-catenin antibodies revealed a stronger cytosolic accumulation of phospho-β-catenin in transgenic osteoblasts and confirmed our previous findings (Fig. 10E ). Furthermore, we examined the expression of Axin 2, a well-known Wnt target, which was significantly downregulated in transgenic osteoblasts overexpressing Pitx1 compared to wild type mouse osteoblasts (Fig. 10F) . Collectively, our data confirm that Pitx1 overexpression in transgenic mice may inactivate the canonical Wnt signaling pathway in osteoblasts by upregulating Dkk1 at the mRNA and protein levels. Interestingly, transgenic mCol1α1-Pitx1 mice treated with 0.01 M of lithium chloride (LiCl), a known GSK3-β inhibitor, were protected from bone loss compared to untreated transgenic mice (Supplementary Information and Figs S4 and S5). MicroCT (µCT) analysis showed significant improvements, mainly in the structural parameters of the trabecular bones of femurs harvested from transgenic mice treated with LiCl, when compared to untreated cells (Table 1 ).
Discussion
Our data demonstrate that PITX1 regulates osteoblastogenesis and osteoclastogenesis in the bone. Using high-resolution microCT, we detected altered cortical and trabecular bone architecture in the long bones of transgenic mCol1α1-Pitx1 mice to reveal a compromised microarchitecture of the bones. One striking feature of the transgenic phenotype is the altered mineralization due to the reduced quantity of bone matrix deposited by osteoblasts. There is a significant reduction in the mineral apposition rate and bone formation rate, which leads to decreased osteoid number and thickness. The altered mineralization and microarchitecture produce a mechanically weaker and immature bone, which could explain the reduced stiffness and strength of the transgenic bones. The significantly reduced expression of osteoblast differentiation markers further support these histomorphometric findings. Furthermore, increased Sost expression, a known osteocyte marker, in transgenic bone suggests an altered maturation rate of osteoblasts into osteocytes, which may explain the altered mineralization observed in vivo and in vitro 11 . Interestingly, PITX1 also appears to contribute to the deregulation of the regulatory osteoblast-osteoclast coupling. In fact, overexpression of PITX1 in osteoblasts increased their capacity to inhibit osteoclastogenesis, by inducing the anti-osteoclastogenic factor, osteoprotegerin (OPG), as evidenced by the elevated plasma OPG levels and the reduced osteoclast number in transgenic bones compared to wild type bones. The parameters reflecting the structure and geometry of the trabecular bone clearly demonstrate the presence of more plate-like structures in transgenic bones (Fig. 2) . This is likely the result of a concurrent decrease in osteoclast number and activity as well as impaired osteoblastogenesis. This phenotype is very similar to senile (type-II) osteoporosis, which differs from the observations of previous studies that link post-menopausal osteoporosis with rod-like trabecular structures and increased osteoclastogenesis 12 . Of note, acute lymphoblastic leukemia (ALL), the most common childhood malignancy, is often associated with decreased bone mineral density, which can lead to fractures, deformity and pain. Interestingly, Halton et al. previously reported a 16% prevalence of vertebral fractures in newly diagnosed childhood ALL cases 13 , while Nagel et al., reported a leukemic activation of PITX1 in 9% of ALL samples tested 14 . Although ALL is primarily a disease of the bone marrow and peripheral blood, any tissue or organ may be infiltrated by leukemic cells 15, 16 . Consistently, histomorphometric studies of bone formation and resorption in newly diagnosed children with ALL showed a decrease in bone volume and trabecular thickness 17 . Moreover, a reduced number of both osteoblasts and osteoclasts with a subsequent decrease in osteoid formation and bone resorption were observed 17 . Despite the fact that the mechanism underlying osteoporosis development in childhood ALL around the time of diagnosis is still poorly understood, the discussed results ressemble those observed in our transgenic mice.
Despite several genome-wide association studies for osteoporosis and/or bone fracture, none of them reported a signal in/or around the PITX1 gene. By studying aging monozygotic twins discordant for osteoporosis, Mak et al., were the first to show an association between PITX1 overexpression and senile osteoporosis 1 . New advances in our understanding of the epigenetics of osteoporosis reveal additional mechanisms by which PITX1 expression could be deregulated in the context of osteoporosis. Indeed, many studies identified circulating microRNA signatures in men and women suffering from osteoporosis [18] [19] [20] . Among others, the expression of miR-19a-3p and miR-19b-3p is downregulated by about 2-fold in the serum of men suffering from idiopathic osteoporosis as well as in women with postmenopausal osteoporosis 18 . Both microRNAs are of interest given their capacity to bind within the 3′UTR of the Pitx1 mRNA leading to its degradation and/or preventing its translation 21, 22 . Furthermore, a recent study by Margolis et al., showed that circulating miR19b-3p expression is downregulated in aging male volunteers when compared to young ones 23 . It should be noted that miR-19a and miR-19b are both www.nature.com/scientificreports www.nature.com/scientificreports/ part of a cluster termed miR-17-92 whose haploinsufficiency in mice causes altered alkaline phosphatase (ALP) activity and reduced bone calcification 24 .
Another important observation of our study is that PITX1 may be a novel negative regulator of the canonical Wnt/β-catenin pathway through the upregulation of Dkk1, Sost, and Gsk3β expression, in transgenic osteoblasts, which results in increased phosphorylation of β-catenin. The upregulation and increased secretion of DKK1, a well-known biomarker of osteoporosis, is an important finding given it normally inhibits osteogenesis and promotes adipogenesis 25, 26 . It is therefore, somewhat surprising that we did not detect greater bone marrow adiposity in transgenic mice. Pitx1 overexpression reduced the number of MSCs and blocked osteogenesis and adipogenesis. The reduction in the number of MSCs could be explained by the fact that PITX1 is a known transcriptional repressor of telomerase reverse transcriptase (TERT) 21, 27 , which plays a role in the survival, growth, and differentiation of mesenchymal stem cells (MSCs) 28 . However, no significant changes were detected in mTert expression in transgenic osteoblasts compared to wild type osteoblasts. Interestingly, overexpression of Pitx1 led to a strong downregulation of Sca-1/Ly6a gene expression in transgenic osteoblasts, which is well known for its role in the regulation of mesenchymal progenitor self-renewal. However, it remains unclear, at this stage, exactly how Pitx1 overexpression represses Sca-1/Ly6 gene expression. Nevertheless, this role is strengthened by the work of Chen et al., (2009) which showed a clear dichotomy between subsets of pituitary stem/progenitor cells, where cells overexpressing Pitx1 were Sca-1-negative, while those that did not express Pitx1 were Sca-1 positive 29 .
Our experimental data and previous studies suggest that PITX1 exerts a dual action within osteoblast cell lineage; it represses the canonical Wnt/β-catenin signaling as well as the expression of Sca-1/Ly6a. Moreover, downregulation of Sca-1/Ly6a induced by Pitx1 overexpression could explain the reduced MSC differentiation capacity as well as the maintenance of an undifferentiated state. Understanding the role of PITX1 in regulating multipotent MSC differentiation might open new avenues for the development of novel therapeutic strategies. Supplementary Fig. S4 . (F) Real time qPCR expression analysis of Axin-2, a known Wnt target, was carried-out in transgenic mCol1α1-Pitx1 and wild type mouse primary osteoblasts. Expression was normalized with that of wild type. Data are presented as mean+/− SD for five mice (females) from each genotype.
Given that osteoporosis is a complex and heterogeneous disease, future studies will be required to confirm the contribution of PITX1 in human senile osteoporosis and more specifically, in some subsets of patients suffering from ALL or idiopathic osteoporosis.
Materials and Methods
Generation of transgenic mCol1α1-Pitx1 mice. Transgenic C57BL/6 mice overexpressing Pitx1 (mCol1α1-Pitx1) in pre-osteoblasts and osteoblasts were generated using a 2.3 kb fragment of the murine promoter for the Col1α1 protein 30 , to control the expression of the coding sequence of Pitx1 (Pitx1 murine cDNA), which was subcloned in a pCI plasmid. A synthetic intron was subcloned between the promoter and the coding sequence, and a polyadenylation cassette was subcloned downstream of the coding sequence in the same vector. The expression vector pCI-mCol1α1-Pitx1 was injected into C57BL/6J ovocytes (IRIC's transgenesis platform, Université de Montréal). The founders were screened for Pitx1 overexpression by PCR using mouse tail genomic DNA. Transgene (TG) expression in tissues was assessed by RT-PCR using two sets of transgene-specific primers Pitx1 (F: 5′-ACTGGGCTTGTCGAGACAGAG-3′; R: 5′-CAGATCAGCGTCGGACGATTC-3′). Four transgenic founders were identified. The transgene lines M22, F30, M42 and M51 were generated by mating founder animals with C57BL/6J mice. We selected the transgene line F30 for further characterization due to its high expression of Pitx1 and its skeletal phenotype. Of note, all transgenic and wild type mice were maintained on a humid diet 5K52 (Lab Diet) since transgenic mice were prone to spontaneous fractures of the mandible and/or hind limbs while on the regular diet, usually deposited at the top of the cage. No significant adverse effect was observed using the humid diet. All the animal experiments were performed in accordance with the protocol (#519) approved by the Animal Ethics Committee of the CHU Sainte-Justine University Hospital Research Center. This study was conducted following the relevant regulations and guidelines.
Radiologic imaging and dual beam X-ray absorptiometry. Ten transgenic mice (females = 5; males = 5) and ten wild type mice (females = 5; males = 5) of 12 weeks of age were analyzed with high resolution X-rays using Faxitron MX20 (Faxitron Corp, IL, USA). The bone mineral density (BMD) was measured with dual-energy X-ray absorptiometry (DXA; PIXIMus II densitometer; GE Healthcare, WI, USA) at 3, 5, and 7 months of age under anesthesia. Other time points were used when appropriate and are indicated.
Microcomputed tomography analysis. The femoral bones of ten transgenic mice (females = 5; males = 5) and ten wild type mice (females = 5; males = 5) of 12 weeks of age were harvested and stored in 70% ethanol at 4 °C. The middle cortical and the trabecular bones of the distal metaphysis were scanned by microcomputed tomography (µCT) using a SkyScan-1072 desktop MicroCT scanner (Bruker microCT, Kontich, Belgium). The femoral bone samples were scanned by an X-Ray source power at 45 kV/222 µA and with 6.25 µm/pixel resolution. The rotation was set at 0.9 degrees per step for 180 degrees and the exposure time was set to 2.8 seconds for each step. The cross sections along the specimen axis were reconstructed using NRecon (v 1.6.1.3, SkyScan). A CT-Analyser (v 1.10.0.1, SkyScan) was employed to perform quantitative analyses and to create 3D models. 3D Creator (v 2.4, SkyScan) was used to manipulate the 3D models and to create 3D images.
Image analyses with ImageJ software. The mean color values of safranin O staining was determined from averaging 7 measurements each of stained histological sections from transgenic and wild type mice. For each measurement, a region of interest (a rectangle) was drawn on the image using ImageJ and the mean pixel intensity (black pixel = 0 and white pixel = 255) of the region of interest (ROI) was measured. These ROIs were drawn around the growth plate matrix (no cell). To obtain the intensity of the staining, the measurements were Table 1 . Lithium treatment of transgenic mCol1α1-Pitx1 mice improves trabecular bone architecture parameters www.nature.com/scientificreports www.nature.com/scientificreports/ Quantification of plasma biomarkers. The levels of RANKL, OPG, DKK1, and SOST in plasma were measured using ELISA kits for RANKL, OPG (Abcam ® ,Toronto, Canada), DKK1, and SOST (R&D Systems, Inc., Minneapolis, USA).
Expression analysis by quantitative real time PCR.
Expression analysis by qPCR for Pitx1, Sca-1 (Ly6a), Tnfsf11, Tnfrsf11b, and Axin2 was performed using TaqMan gene expression probes for mice with Gapdh as an endogenous control (Pitx1 #Mm00440824_m1; Ly6a #Mm00726565_s1; Tnfsf11 #Mm00441906_ m1; Tnfrsf11b #Mm00435454_m1; Axin2 #Mm00443610_m1; Gapdh #Mm99999915_g1). The TaqMan Fast Advanced mastermix was used by following the manufacturer's instructions (Thermo Fisher Scientific). Analysis was performed using the 7500-Fast Real Time instrument (Thermo Fisher Scientific). The ΔΔCT method was used for qPCR data analysis.
Statistical analysis. The data were evaluated statistically using Student's t test in SPSS Windows, version 10.0. Results are shown as mean ± standard deviation (SD). The p values were considered significant at *p < 0.05, **p < 0.01, and ***p < 0.001.
